Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Bacopa Monnieri wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
4 of 7 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Bacopa Monnieri and Kava have evidence — compare verdict strength side-by-side.
300-450mg daily (standardized to 50% bacosides)
With fatty meal for absorption
Bacognize® or Synapsa® standardized extract
150-300mg kavalactones daily
Evening for relaxation, 30-60 minutes before stressful events, Before bed for sleep
Water-extracted root powder or capsules
8-12 weeks
8-12 weeks
First 2 weeks
First week
30-60 minutes
30-60 minutes
30-60 minutes
1-2 hours
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review
Nutrients (2025) · Systematic review
The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance.
Effectiveness of Bacopa Monnieri (Brahmi) in the management of schizophrenia: a systematic review
Nutritional neuroscience (2025) · Systematic review · n=103
Schizophrenia is a psychotic disorder affecting approximately 0.32% of the global population.
Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability
Nutrients (2025) · Systematic review
Animal studies have shown promising results in reducing symptoms and protecting against neurodegeneration.
Herbal medicines in the treatment of psychiatric disorders: 10-year updated review
Phytotherapy research : PTR (2018) · Systematic review
Other encouraging herbal medicines with preliminary evidence include Curcuma longa (turmeric) in depression, Withania somnifera (ashwagandha) in affective disorders, and Ginkgo biloba (ginkgo) as an adjunctive treatment in Schizophrenia.
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Phytotherapy research : PTR (2018) · Systematic review
An open-ended search to 5 July 2017 was conducted using MEDLINE (PubMed), Scopus, and Cochrane library online databases and performed in a stepped format from preclinical to clinical investigations.
Herbal medicine for insomnia: A systematic review and meta-analysis
Sleep medicine reviews (2015) · Meta analysis · n=1602
There was no statistically significant difference between any herbal medicine and placebo, or any herbal medicine and active control, for any of the thirteen measures of clinical efficacy.
Based on meta-analysis of 437 participants showing improvements in attention, processing speed, and working memory. However, one large RCT (n=101) found no significant between-group differences. Effects may take 8-12 weeks to manifest. Standardized extracts (Bacognize, Synapsa) may have better bioavailability than generic forms.
Based on multiple meta-analyses showing efficacy vs placebo with effect size comparable to benzodiazepines for mild-moderate anxiety. WS1490 extract showed OR=3.3 vs placebo. Effectiveness limited to 60% due to mixed results in some GAD populations and study quality limitations.
AI-estimated from published studies. Interpret as directional guidance.
Bacopa Monnieri has a higher evidence score (8.5/10 vs 9/10) and wins in 2 of 3 categories.
For reduce anxiety & stress, Kava has a higher relevance score (90 vs 65).
No known interactions between Bacopa Monnieri and Kava have been documented in our database. However, always consult a healthcare provider before combining supplements.